{{Rsnum
|rsid=13420827
|Gene=DNMT3A
|Chromosome=2
|position=25231099
|Orientation=plus
|GMAF=0.2144
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=DNMT3A
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 70.8 | 26.2 | 3.1
| HCB | 71.1 | 26.7 | 2.2
| JPT | 77.8 | 17.8 | 4.4
| YRI | 66.1 | 32.3 | 1.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 71.1 | 26.7 | 2.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

{{PMID|18381459|OA=1
}} 829 Caucasian cases with primary epithelial ovarian cancer and 941 frequency-matched unaffected controls 
Three SNPs in DNMT3A were associated with risk among multivitamin supplement users: 
*3' untranslated region (UTR) C>G ([[rs13420827]]: OR, 0.8; 95% CI, 0.6-1.0; P interaction = 0.006; FPRP = 0.54)
*intron 6 G>A ([[rs11887120]]: OR, 0.8; 95% CI, 0.7-1.0; P interaction = 0.007; FPRP = 0.57)
*intron 22 A>T ([[rs11695471]]: OR, 1.2; 95% CI, 1.0-1.5; P interaction = 0.01; FPRP = 0.66)

{{PMID Auto
|PMID=20570913
|Title=Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium.
|OA=1
}}

{{on chip | HumanOmni1Quad}}